5F-SDB-006
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1776086-02-2 |
ChemSpider | 30646773 |
Chemical data | |
Formula | C21H23FN2O |
Molecular mass | 338.43 g/mol |
|
|
|
5F-SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 of 50 nM for human CB1 receptors, and 123 nM for human CB2 receptors.[1] It was discovered during research into the related compound APICA which had been sold illicitly as "2NE1".[2] 5F-SDB-006 is the terminally fluorinated analog of SDB-006, just as STS-135 is the terminally fluorinated analog of APICA.
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Cannabinoids
- Designer drugs
- Indoles
- Indolecarboxamides
- Organofluorides
- Cannabinoid stubs